Hawaii Senate Bill SCR51

Hawaii 2026 Regular Session

• Introduced: 3/10/26
• Refer: 3/19/26

Caption

Requesting The Auditor To Assess The Social And Financial Effects Of Requiring Health Insurers To Provide Coverage For Medically Necessary Proton Beam Therapy For Cancer Treatment.

Impact

The resolution highlights the inadequacies in current insurance coverage for proton beam therapy, which can leave patients without necessary access to optimal treatment. By calling for an assessment in accordance with sections 23-51 and 23-52 of the Hawaii Revised Statutes, SCR51 aims to pave the way for a more comprehensive approach to health insurance that aligns with medically established needs. If implemented, this could lead to improved health outcomes for cancer patients in Hawaii by ensuring that essential therapies are included in insurance policies.

Summary

SCR51 is a Senate Concurrent Resolution that requests the Auditor to assess the social and financial effects of mandating health insurers to cover medically necessary proton beam therapy for cancer treatment. This comes in response to the challenges that patients face in accessing this advanced form of radiation therapy, which has the potential to deliver more precise treatment with fewer side effects compared to traditional methods. As cancer remains a leading health concern in Hawaii, the resolution aims to ensure that effective treatment modalities are available to those who need them the most.

Contention

While the bill seeks to improve access to proton beam therapy, there may be discussion surrounding the financial implications for insurers and whether such mandates could lead to increased insurance costs. Opponents of mandated coverage often raise concerns about the sustainability of insurance models in light of these requirements, whereas proponents argue that the benefits of improved patient outcomes far outweigh potential financial burdens on insurers.